Key research themes
1. How are targeted biologic therapies shaping the management of severe asthma phenotypes and endotypes?
This research theme focuses on the evolution of asthma management from broad-spectrum treatments toward personalized therapies that specifically target distinct immunological pathways and asthma endotypes. Understanding severe asthma phenotypes, characterized by different inflammatory markers such as eosinophilia and IgE levels, has enabled the development and use of biological agents like anti-IgE and anti-IL-5 antibodies. These advances are critical for improving outcomes in patients with treatment-refractory severe asthma who do not adequately respond to conventional pharmacotherapies.
2. What is the role and efficacy of non-pharmacological and adjunct therapies, including self-management and physiotherapeutic interventions, in improving asthma control?
This theme investigates the integration of non-pharmacological treatments such as breathing exercises, patient self-management education, psychological support, and advanced adjuncts in acute and refractory asthma management. Recognizing asthma as a complex, multi-dimensional disease with psychosocial components and variable clinical trajectories, this approach addresses unmet needs beyond pharmacology to enhance quality of life, symptom control, and reduce exacerbations.
3. How do diagnostic accuracy, phenotypic differentiation, and comorbidities influence asthma management and control in clinical practice?
This area focuses on the challenges of accurately diagnosing asthma, differentiating among phenotypes especially in pediatric populations, and addressing comorbid conditions and behavioral factors that impact disease control. It underscores the importance of using objective diagnostic tools, recognizing asthma mimickers, and integrating a comprehensive patient evaluation to optimize treatment strategies and reduce misdiagnosis or inappropriate therapy.